this post was submitted on 09 Aug 2021
0 points (NaN% liked)

health

197 readers
3 users here now

founded 4 years ago
MODERATORS
 

According to the US Food and Drug Administration (FDA), there has been an evident increase in the number of cell and gene therapy products being evaluated in early phases of development. This can further be validated by the observed upsurge in the number of investigational new drug (IND) applications.

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here